Vigil Neuro
Evangelia Hatzis PhD PMP serves as the Senior Director of Program Management at Vigil Neuroscience, with prior roles including Senior Director of Program Leadership at Lyra Therapeutics and Flexion Therapeutics. Evangelia held the position of VP and Senior Director of Project and Portfolio Management at Frequency Therapeutics, and Director of Project Management and Operations at EMD Serono, Inc. Experience also includes project management at Pfizer and Biogen Idec, where contributions spanned from leading pre-clinical development to managing cross-functional teams in clinical studies. Educational credentials include a Ph.D. in Immunology from Jefferson Health and a Bachelor of Science in Biology from Haverford College.
This person is not in any offices
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.